Source: Applied Microbiology and Biotechnology. Unidades: FCF, BIOTECNOLOGIA, IQ
Subjects: GRANULÓCITOS, ESCHERICHIA COLI
ABNT
EGUIA, Fara A. P et al. Development of recombinant human granulocyte colony-stimulating factor (nartograstim) production process in Escherichia coli compatible with industrial scale and with no antibiotics in the culture medium. Applied Microbiology and Biotechnology, v. 105, p. 169–183, 2021Tradução . . Disponível em: https://doi.org/10.1007/s00253-020-11014-y. Acesso em: 18 ago. 2024.APA
Eguia, F. A. P., Mascarelli, D. E., Carvalho, E. de, Rodríguez, G. R., Makiyama, E. N., Borelli, P., et al. (2021). Development of recombinant human granulocyte colony-stimulating factor (nartograstim) production process in Escherichia coli compatible with industrial scale and with no antibiotics in the culture medium. Applied Microbiology and Biotechnology, 105, 169–183. doi:10.1007/s00253-020-11014-yNLM
Eguia FAP, Mascarelli DE, Carvalho E de, Rodríguez GR, Makiyama EN, Borelli P, Lieberman C, Ho PL, Barazzone GC, Gonçalves VM. Development of recombinant human granulocyte colony-stimulating factor (nartograstim) production process in Escherichia coli compatible with industrial scale and with no antibiotics in the culture medium [Internet]. Applied Microbiology and Biotechnology. 2021 ; 105 169–183.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1007/s00253-020-11014-yVancouver
Eguia FAP, Mascarelli DE, Carvalho E de, Rodríguez GR, Makiyama EN, Borelli P, Lieberman C, Ho PL, Barazzone GC, Gonçalves VM. Development of recombinant human granulocyte colony-stimulating factor (nartograstim) production process in Escherichia coli compatible with industrial scale and with no antibiotics in the culture medium [Internet]. Applied Microbiology and Biotechnology. 2021 ; 105 169–183.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1007/s00253-020-11014-y